Target : International, multicenter trial comparing the use of enoxaparine IV versus standard IV heparine in patients presenting acute myocardial infarction to be treated with primary percutaneous coronary intervention.
Trial date : 2008
Number of patients : 910
Source of funding : Public (APHP) et private (Sanofi-Aventis)
Centers participating : 73 centers in 4 countries (51 french, 13 german, 6 austrian and 3 american centers)
N°NCT : NCT00718471